GlassScriptPhysician profile
Izolda Mikhaylov
NPI 1093734055
$960.84
in general payments reported to CMS, 2019-2025
18 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.24 · 2020: $79.16 · 2021: $178 · 2022: $130 · 2023: $95.74 · 2024: $164 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $176.62 | 2021-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Lilly USA, LLC | $133.17 | 2020-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $106.21 | 2019-2022 | |
| Amgen INC. | $88.38 | 2021-2025 | Otezla, Repatha |
| Pfizer INC. | $64.59 | 2024-2025 | |
| Glaxosmithkline, LLC. | $53.35 | 2021-2025 | Trelegy Ellipta |
| Alk-Abello, INC | $44.20 | 2023-2025 | Grastek, Ragwitek, Odactra |
| Baxter Healthcare | $41.66 | 2024 | Hillrom - Connex Spot Monitor |
| Regeneron Healthcare Solutions, INC. | $39.84 | 2022 | |
| Ardelyx, INC. | $31.82 | 2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $29.58 | 2024 | |
| Abbvie INC. | $28.48 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $24.12 | 2021 | |
| Oxford Immunotec USA INC | $21.92 | 2022 | |
| Axsome Therapeutics, INC. | $21.67 | 2025 | Symbravo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.54 | 2025 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $17.96 | 2021 | |
| Phadia US INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Izolda Mikhaylov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.